Re: Clinical experience across the fetal-fraction spectrum of a non-invasive prenatal screening approach with low test-failure rate
Ultrasound Obstet Gynecol
.
2020 Sep;56(3):471-472.
doi: 10.1002/uog.22104.
Authors
R Jelsema
1
,
Z P Demko
1
,
P R Billings
1
Affiliation
1
Natera, Inc, San Carlos, CA, USA.
PMID:
32870585
PMCID:
PMC7522681
DOI:
10.1002/uog.22104
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Aneuploidy*
Female
Fetus
Humans
Pregnancy
Prenatal Diagnosis*